# NBE-Therapeutics funding: rounds and investors

> NBE-Therapeutics has raised $25M across 2 rounds since 2015. Investors include Boehringer Ingelheim Venture Fund and Novo Holdings. Every round with its source.

Source: https://millionrounds.com/company/nbe-therapeutics (Millionrounds; every figure on the page links to its filing or article)

Switzerland · [Series C startup](https://millionrounds.com/companies)

# Who invested in *NBE-Therapeutics*

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summary Updated 26 Oct 2026

**$25M** raised across 2 rounds since 2015, from 2 sources

**$3.1M** Series A **$22M** Series C

- **Latest round:** Series C, $22M Jan 2020
- **Step-up i:** 7.1×
- **Investors:** 2

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2015 2016 2017 2018 2019 2020

**$3.1M** Series A

**$22M** Series C

- **First round:** Series A, $3.1M
- **Biggest round:** $22M
- **Between rounds:** 4.8 years

## The rounds

- **Jan 2020** Series C **$22M** *1 new* *1 returning* [Novo Holdings](https://millionrounds.com/fund/novo-ventures) [Boehringer Ingelheim Venture Fund](https://millionrounds.com/fund/boehringer-ingelheim-venture-fund) Source recorded
- **Mar 2015** Series A **$3.1M** *1 new* [Boehringer Ingelheim Venture Fund](https://millionrounds.com/fund/boehringer-ingelheim-venture-fund) From a historical funding record

## Founders and team

From NBE-Therapeutics's own website: 3 on the team.

- **Andy Bross** Chief Financial Officer
- **Dr. Carl Deutsch** Chief Scientific Officer
- **Dr. Olof Prause** Chief Operating Officer

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Series A** 2015 **Series C** 2020 [Boehringer Ingelheim Venture Fund](https://millionrounds.com/fund/boehringer-ingelheim-venture-fund) [Novo Holdings](https://millionrounds.com/fund/novo-ventures)

## Everyone who backed them

[Boehringer Ingelheim Venture Fund](https://millionrounds.com/fund/boehringer-ingelheim-venture-fund) Corporate VC **2** rounds

[Novo Holdings](https://millionrounds.com/fund/novo-ventures) VC firm **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=nbe-therapeutics).

## Quick answers about NBE-Therapeutics

### Who invested in NBE-Therapeutics?

NBE-Therapeutics's investors include Boehringer Ingelheim Venture Fund and Novo Holdings.

### How much has NBE-Therapeutics raised?

NBE-Therapeutics has raised $25M across 2 rounds since 2015.

### When did NBE-Therapeutics last raise?

NBE-Therapeutics's most recent round was a Series C of $22M in Jan 2020.

### What was NBE-Therapeutics's biggest round?

Its most recent round, $22M in Jan 2020, is also its largest on record.

### Who backed NBE-Therapeutics first?

NBE-Therapeutics's first round on record, in Mar 2015, was backed by Boehringer Ingelheim Venture Fund.

### What stage is NBE-Therapeutics at?

NBE-Therapeutics's latest named round is a Series C, in Jan 2020.

### Where is NBE-Therapeutics based?

NBE-Therapeutics is based in Switzerland.

## Companies like NBE-Therapeutics

In the same sector, and raised in the last eighteen months.

[**Nouscom** $191M · Oct 2026](https://millionrounds.com/company/nouscom)[**ADC Therapeutics** $646M · Oct 2026](https://millionrounds.com/company/adc-therapeutics)[**AnaCardio** $89M · Oct 2026](https://millionrounds.com/company/anacardio)[**NovaGo Therapeutics** $40M · Sept 2026](https://millionrounds.com/company/novago-therapeutics)[**Prevision Medicine** $5.4M · Sept 2026](https://millionrounds.com/company/prevision-medicine)[**Microcaps** $10M · Jul 2026](https://millionrounds.com/company/microcaps)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app